跳至主要内容
临床试验/IRCT20210715051904N1
IRCT20210715051904N1招募中3 期

Efficacy of combination therapy of L-glutamine and Hydroxyurea in comparison with Hydroxyurea alone in patients with sickle cell anemia: a randomized, double-blinded clinical trial

Boushehr University of Medical Sciences0 个研究点目标入组 126 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
126

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
5 years 至 no limit(—)
性别
All

入选标准

  • Patients with sickle-cell syndrome
  • Age more than five-year-old
  • No other accompanying hematologic diseases
  • All patients should be on Hydroxyurea
  • At least two (extreme) pain crises have been documented in the past year (defining a pain crisis as pain that results from treatment with a drug or injectable ketorolac in the emergency department (ED) (or outpatient treatment center) or during hospitalization. Becomes)

排除标准

  • Occurrence of life-threatening events not related to SCD during treatment
  • Patient dissatisfaction with participation in the study
  • Serum albumin levels are less than 3 g / dL
  • Internationally normalized ratios of prothrombin time are higher than 2.0
  • The treated with L-glutamine within 30 days prior to screening.

研究者

发起方
Boushehr University of Medical Sciences

相似试验

The effect of combination therapy of L-glutamine and... | 临床试验